US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イタリア
BIT
Next Re SIIQ SpA (NR) 銘柄情報

Next Re SIIQ SpA (NR)

0.00

0.00

(0.00%)

終了 6月15日 12:30AM

Next Re SIIQ SpA (NR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

2.82 52 週間の範囲 3.44

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

2,099 €

発行済株式数

21,987,404

配当利回り

0.03 (1.14%)

PER

72.68

1 株当たり利益 (EPS)

0.04

歳入

4.43M

純利益

901.78k

Next Re SIIQ S.p.A. operates as a real estate investment company in Italy. It manages a portfolio of office and commercial properties, focusing on the acquisition, ownership, and leasing of assets located in major Italian cities, including Milan, Rome, and Bari. As of December 31, 2024, the portfoli... Next Re SIIQ S.p.A. operates as a real estate investment company in Italy. It manages a portfolio of office and commercial properties, focusing on the acquisition, ownership, and leasing of assets located in major Italian cities, including Milan, Rome, and Bari. As of December 31, 2024, the portfolio consists of six fully leased properties, including three for commercial use and three primarily for managerial (office) use. The company was formerly known as Nova Re SIIQ S.p.A. and changed its name to Next Re SIIQ S.p.A. in November 2021. It was incorporated in 1977 and is headquartered in Rome, Italy. 詳細を表示

セクター

Real Estate

業界

Real Estate

ウェブサイト

www.nextresiiq.it

本社

Rome, Italy

設立

1977

Next Re SIIQ SpA is listed in the Real Estate sector of the イタリア証券取引所 with ticker NR. The last closing price for Next Re SIIQ was -. Over the last year, Next Re SIIQ shares have traded in a share price range of 2.82 € to 3.44 €.

Next Re SIIQ currently has 21,987,404 shares in issue. Next Re SIIQ has a price to earnings ratio (PE ratio) of 72.68.

Newpark Resources to Present at the FBR Capital Markets 2009 Fall Investor Conference

THE WOODLANDS, Texas, Nov. 24 /PRNewswire-FirstCall/ -- Newpark Resources, Inc. (NYSE:NR) announced today that Paul Howes, President and Chief...

Newpark Resources Announces Results of Special Meeting of Stockholders

THE WOODLANDS, Texas, Nov. 3 /PRNewswire-FirstCall/ -- Newpark Resources, Inc. (NYSE:NR) announced today that at a special meeting of...

Newpark Resources Reports Third Quarter 2009 Results

Revenues and net income improve sequentially from second quarter 2009 THE WOODLANDS, Texas, Oct. 29 /PRNewswire-FirstCall/ -- Newpark Resources...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	3	3.02	2.98	4135	2.98	DE
4	0	0	2.98	3.02	2.98	2870	2.98	DE
12	0	0	2.94	3.02	2.92	1726	2.9768007	DE
26	0	0	2.86	3.08	2.82	1338	2.95412791	DE
52	0	0	3.12	3.44	2.82	1255	3.00376444	DE
156	0	0	3.34	3.54	2.82	1255	3.12102018	DE
260	0	0	3.56	6.5	2.82	3190	3.78766733	DE

NR - Frequently Asked Questions (FAQ)

What is the current Next Re SIIQ SpA share price?

The current share price of Next Re SIIQ SpA is 0.00 €

How many Next Re SIIQ SpA shares are in issue?

Next Re SIIQ SpA has 21,987,404 shares in issue

What is the 1 year trading range for Next Re SIIQ SpA share price?

Next Re SIIQ SpA has traded in the range of 2.82 € to 3.44 € during the past year

What is the PE ratio of Next Re SIIQ SpA?

The price to earnings ratio of Next Re SIIQ SpA is 72.68

What is the cash to sales ratio of Next Re SIIQ SpA?

The cash to sales ratio of Next Re SIIQ SpA is 14.79

What is the registered address of Next Re SIIQ SpA?

The registered address for Next Re SIIQ SpA is Via Zara, 28, Rome, Rome, 00198

What is the Next Re SIIQ SpA website address?

The website address for Next Re SIIQ SpA is www.nextresiiq.it

Which industry sector does Next Re SIIQ SpA operate in?

Next Re SIIQ SpA operates in the Real Estate sector

Hi_Lo

This will trade forever as long as there is volume. Bidding here at rock bottom. This will never be a FINRA delete as long as there is volume.
NV SoS a new entity will scoop this up and finish the Sharp legend 🚀
Google Gemini

https://g.co/gemini/share/4e20adf2ce7

Gmenfan

Gmenfan 1分前

SkyLimit2022

SkyLimit2022 1分前

theorysuit,

Is the FDA “pumping” too by approving the new
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177686613 P2 combo trial to proceed? 🙄

“Authorization of a Phase 2 trial represents more than permission to continue development

Steady_T

Steady_T 2分前

Why would you drive a company in financial straights into bankruptcy by spending money to get licensed in a market that it can't support?

At the time the UK application was filed the approval decision was expected in a reasonable time and that would have allowed the company to obtain

WarMachine

WarMachine 3分前

If the deal sticks this time $SCO will at minimum double.

Gmenfan

Gmenfan 3分前

InfiniteHaven63

InfiniteHaven63 4分前

Happy Sunday to all my BLEG peeps!

RIGATONI

RIGATONI 4分前

~DTREF .09...

Reminder and this new article...

Again, China is behind this drop imo...

June 9th..

Gmenfan

Gmenfan 5分前

Oh dear................ :-)

joe botts

joe botts 7分前

Lol! Whew lunch and Applebee's for dinner money.

ddls

All this enthusiasm for a stock that trades 10 or less times a day. More posts than trades....hmmmmmmm!

joe botts

joe botts 9分前

No way what about Wertheim! Lmao

BIOChecker4

BIOChecker4 10分前

“CROs were responsible for the data and they are not combing through their work.“

You could not possibly know this. You are making a supposition that is not supported by any evidence.

As for no need to check every nook and cranny, the exact opposite is true. Every bit

luckydude777

luckydude777 13分前

Sure hope the "deal" is legit. Will be nice if it is.

BIOChecker4

BIOChecker4 15分前

Your logic is flawed. How would Dr. K. Know the AD data are good when the trials that generated the data were flawed? This is the reason large, well designed phase 3 trials are necessary and will be required by drug regulators.

theorysuit

theorysuit 15分前

Don't worry all the people posting on here are paid pumps. That's why they are apologizing and assigning blame to anyone but nwbo. No sane investor would be happy with this lying POS company who has failed in so many ways.

These small pumps for the company to offload thei

NYATC

Let hope they don’t “screw the pooch”. You know that one? 😆

AJH92

$ECOX Overview - Updated June 13, 2026

New CEO: Richard C Hawkins wef April 2, 2025

Reverse Merger With Kepler GTL

Letter of Intent to Combine [source: PR February 17, 2026]

- On February 12, 2026 entered into a non-binding Letter of Intent

ddls

This stock is finished, done, the end...but you go ahead and dream of something else.

HyGro

NWBO didn't have much choice. FDA took a pass, EU is more difficult, so UK looked like their best option.

The EU requires interaction with multiple bodies: EMA scientific assessment via rapporteurs, CHMP opinion, and then EC legal decision, plus subsequent national pricing/HTA negot

nwsun

Hopefully we all make a big gain on another investment and we can use sflm as a full write off against those gains.

theorysuit

theorysuit 20分前

Oh sure blame the mhra for it taking this long. Where are the other applications/submissions LP In promised 3 years ago. Do you want to blame that on MHRA too? Blame anyone else is their mantra .......lmfao. Is that why LP says they won't update on status? Protesting the rejection?Lmfao at

William777

William777 20分前

(Nutanomics) also known as NNI produced and branded its own product line, and began to sell to the retail outlets and to the public. NNI has also produced formulas for hundreds of other companies. Trademarks, Tradenames, and Patents: NNI®, NutraNomics®, HEC®, Health Education Corporation®, AES®, Ass

Vexari

Vexari 20分前

Brian's Song (1971)

This highly acclaimed winner of five Emmy Awards

It's the true story of a special relationship between two professional football players

Gale Sayers (Billy Dee Williams) and Bria

Phx Ko Nts Car 12/23/2027

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。